Actively Recruiting
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Led by Boston Scientific Corporation · Updated on 2026-05-07
200
Participants Needed
4
Research Sites
617 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
CONDITIONS
Official Title
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)
- Signed a valid, IRB/EC/REB-approved informed consent form
You will not qualify if you...
- Meets any contraindications per locally applicable Directions for Use (DFU)
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Uniklinik Köln
Cologne, Germany
Actively Recruiting
2
Universitaetsklinikum Dusseldorf
Düsseldorf, Germany
Actively Recruiting
3
Universitaetsklinikum Wuerzburg
Würzburg, Germany
Actively Recruiting
4
St. Georges Hospital
London, United Kingdom
Actively Recruiting
Research Team
S
Stephanie Delvaux
CONTACT
D
Diane Keesey
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here